Loading...
    Loading...
    LEADERBOARD
labroots
Login here
Register Free
  • LOGIN
  • REGISTER FREE
  • Home
  • Virtual Events
      • Upcoming
      • On-Demand
      • Companies
      • Posters
      • Categories
      See More
      See More
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Plants & Animals
      • Earth & The Environment
      • Chemistry & Physics
      • Technology
      • Cannabis Sciences
      • Drug Discovery & Development
  • Webinars
      • Upcoming
      • On-Demand
      • Categories
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Plants & Animals
      • Earth & The Environment
      • Chemistry & Physics
      • Technology
      • Cannabis Sciences
      • Drug Discovery & Development
  • Trending News
      • Most Recent
      • What's Hot
      • Categories
      See More
      See More
      • Health & Medicine
      • Clinical & Molecular DX
      • Immunology
      • Cardiology
      • Cancer
      • Cell & Molecular Biology
      • Genetics & Genomics
      • Microbiology
      • Neuroscience
      • Drug Discovery & Development
      • Plants & Animals
      • Cannabis Sciences
      • Earth & The Environment
      • Space & Astronomy
      • Chemistry & Physics
      • Technology
  • Multimedia
      • Sponsored Content
      • eBooks
      • Podcasts
      • Infographics
      See More
      See More
      See More
      See More
  • Products
      • Categories
      • Companies
      • New
      • Popular
      Antibodies
      Immunity, Immunoassay, Immunotherapy
      Assay Kits
      Detection, Quantification
      Biomolecules
      Proteins
      Cell Biology
      Cell function
      Cell-Based Assays
      Cell viability
      Cell/Tissue Culture
      Cell lines, Cell growth, Cell differentiation
      Chemicals and Reagents
      Reagent kits, Laboratory chemicals
      Drug Discovery and Development
      Target identification, High-throughput screening
      Flow Cytometry
      Immunophenotyping, Cell cycle analysis
      Genomics
      Genome sequencing, Transcriptomics
      Imaging (Bio-Imaging / Microscopy)
      Fluorescence imaging
      Lab Automation
      High-throughput screening, Robotics, Liquid handling systems
      Lab Equipment
      Centrifuges, Incubators, Homogenizers, Sonicators
      Life Sciences
      Biological research, Biotechnology
      Molecular Biology
      DNA replication, Gene expression, PCR
      Next Gen Sequencing
      DNA sequencing, High-throughput sequencing, NGS platforms, RNA sequencing, miRNA sequencing, Accessory Products
      Quality Control and Validation
      QC standards, Quality assurance
      Single Cell Analysis
      Transcriptomics
      Technology
      Biotechnology, Instrumentation, Data analysis
      See More
      See More
      See More
  • Companies
      • See More
    • Science Store
        • Men's T-Shirts
        • Women's T-Shirts
        • Accessories
        • Gift Cards
        • Gift Card Balance
        See More
        See More
        See More
        Gift Card $25
        Gift Card $50
        Gift Card $75
        Gift Card $100
        See More
        Labroots Store Gift Card Balance
        $0.00
        Balance
        Gift Card Number:

        No gift card matches the entered value.

    • Continuing Education
    • More
      • Virtual Events
        • All Virtual Events
        • Upcoming
        • On-Demand
        • Posters
        • Companies
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Plants & Animals
        • Earth & The Environment
        • Chemistry & Physics
        • Technology
        • Cannabis Sciences
        • Drug Discovery & Development
        Webinars
        • All Webinars
        • Upcoming
        • On-Demand
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Plants & Animals
        • Earth & The Environment
        • Chemistry & Physics
        • Technology
        • Cannabis Sciences
        • Drug Discovery & Development
        Trending News
        • Most Recent
        • What's Hot
        • Health & Medicine
        • Clinical & Molecular DX
        • Immunology
        • Cardiology
        • Cancer
        • Cell & Molecular Biology
        • Genetics & Genomics
        • Microbiology
        • Neuroscience
        • Drug Discovery & Development
        • Plants & Animals
        • Cannabis Sciences
        • Earth & The Environment
        • Space & Astronomy
        • Chemistry & Physics
        • Technology
        Multimedia
        • Sponsored Content
        • eBooks
        • Podcasts
        • Infographics
        Store
        Companies
        Science Store
        • Men's T-Shirts
        • Women's T-Shirts
        • Accessories
        • Gift Cards
        • Gift Card Balance
        Continuing Education
        Company
        • About Us
        • The Team
        • Careers
        • Press Room
        • Social Media
        • Press Releases
        • Editorial & Writing Team
        • Blog
        • Scholarships
        • RSS
        • Contact Us
        • Continuing Education
        • Leaderboard
        Advertise
        • Media Kit
        • Custom Virtual Events
        • Virtual Event Series
        • Hybrid Events
        • Digital Advertising
        • Webinars
        • Rate Card
        • Editorial Calendar
        • Posters
        • Case Studies
        • Testimonials
        • Request Demo
        Forms
        • Audience Selection Form
        • Social Media Preference Forms
        • Custom Virtual Event Email Form
        • Sponsored Content Selection Form
        Legal
        • Terms and Conditions
        • Privacy Policy
        • Order Policy
        • Shipping Policy
        • Copyrights
        • User Agreement
        • User Data Request
        Support
        Company
        • About Us
        • The Team
        • Careers
        • Press Room
        • Social Media
        • Press Releases
        • Editorial & Writing Team
        • Media Partnerships
        • Blog
        • Scholarships
        • Continuing Education
        • Leaderboard
        • Contact Us
        Advertise
        • Media Kit
        • Custom Virtual Events
        • Virtual Event Series
        • Hybrid Events
        • Digital Advertising
        • Webinars
        • Rate Card
        • Editorial Calendar
        • Posters
        • Case Studies
        • Testimonials
        • Request Demo
        Forms
        • Audience Selection Form
        • Social Media Preference Forms
        • Custom Virtual Event Email Form
        • Sponsored Content Selection Form
        Legal
        • Terms and Conditions
        • Privacy Policy
        • Order Policy
        • Shipping Policy
        • Copyrights
        • User Agreement
        • User Data Request
        Request Demo
        Interested in Advertising
        with Labroots?
        Have questions? Visit our Support pages
    Login here
    Register Free
    Follow

    Genitourinary cancers

    Genitourinary cancers are malignancies involving organs of the male reproductive or urinary systems of men or woman. Genitourinary cancers include adrenal, bladder, kidney, penile, prostate, and testicular cancers. There are a broad range of treatment regimens used to treat genitourinary cancers depending on factors such as the type and stage of disease and the patient's overall health and comorbidities.

    Webinars

    • OCT 30, 2023 | 8:00 PM
      Capillary electrophoresis in cancer research today:
      Capillary electrophoresis in cancer research today:
      Description: Join this two-part webinar to learn how capillary electrophoresis (CE) complements sequencing technologies, such as next generation sequencing, that are being used by cancer res...
      Speaker: Steve Jackson, PhD , Dr. Somak Roy, MD
      Sponsored By: Thermo Fisher Scientific
      11
      OCT 26, 2023 | 8:00 AM
      Capillary electrophoresis in cancer research today:
      Capillary electrophoresis in cancer research today:
      Description: Join this two-part webinar to learn when capillary electrophoresis is an ideal choice relative to other various sequencing technologies – such as next generation sequencin...
      Speaker: Steve Jackson, PhD , Dr. Somak Roy, MD
      Sponsored By: Thermo Fisher Scientific
      23
      JUN 02, 2021 | 12:00 AM
      IDO in Melanoma..... Deserves Further Evaluation
      IDO in Melanoma..... Deserves Further Evaluation
      Learning Objectives: 1. Learn about IDO pathway 2. IDO rule in cancer...
      Speaker: Yousef Zakharia, MD
      Presented at: Immuno-Oncology Virtual Event Series 2021
      1
      OCT 21, 2020 | 9:25 PM
      The role of PARPis and HRD testing in advanced ovarian cancer
      The role of PARPis and HRD testing in advanced ovarian cancer
      High grade serous ovarian cancer is characterized by genomic instability, with ~50% of advanced tumors harboring homologous recombination repair (HRR) pathway deficiency (HRD). HRD results i...
      Speaker: Natalie Ngoi, MBBS, MMed, MRCP
      Presented at: OncomineWorld Autumn: A virtual NGS education meeting
      1
      OCT 21, 2020 | 9:25 PM
      The role of PARPis and HRD testing in advanced ovarian cancer
      The role of PARPis and HRD testing in advanced ovarian cancer
      High grade serous ovarian cancer is characterized by genomic instability, with ~50% of advanced tumors harboring homologous recombination repair (HRR) pathway deficiency (HRD). HRD results i...
      Speaker: Natalie Ngoi, MBBS, MMed, MRCP
      Presented at: OncomineWorld 2022: A Virtual NGS Education Meeting
      0
      OCT 07, 2020 | 12:00 AM
      Immunotherapy in Prostate and Renal Cell Carcinoma: Panoply of Futuristic Therapies
      Immunotherapy in Prostate and Renal Cell Carcinoma: Panoply of...
      Immune therapy approaches are being used in many different solid cancers today including clear cell renal carcinoma (mccRCC) and metastatic prostate adenocarcinoma. Over the past few years i...
      Speaker: Benjamin Maughan, MD, PharmD
      Presented at: Cancer Research & Oncology Week Virtual Event Series 2020
      4
      JUN 03, 2020 | 6:00 AM
      Keynote Presentation: Development of Rational Immunotherapy Combinations to Overcome the Immunosuppressive Prostate Tumor Microenvironment
      Keynote Presentation: Development of Rational Immunotherapy Combinations...
      Immune checkpoint therapies targeting the CTLA-4 and PD-(L)1 pathways have been largely clinically disappointing for patients with prostate cancer. This can be attributed to the highly immun...
      Speaker: Sumit K. Subudhi, MD, PhD
      Presented at: Immuno-Oncology Virtual Event Series 2020
      1
      JUN 03, 2020 | 12:00 AM
      Define challenges of tissue-based biomarker development for Immuno-Oncology Therapy
      Define challenges of tissue-based biomarker development for Immuno-Oncology...
      Learning Objectives: 1. Define applications of approved and experimental (multiplexing IF) biomarker assessment in Immuno-Oncology 2. Define bottlenecks and areas of improvement to current t...
      Speaker: Houssein Sater, MD
      Presented at: Immuno-Oncology Virtual Event Series 2020
      1
      JUN 03, 2020 | 12:00 AM
      Clinical Development of Immunotherapy in Urothelial Cancer
      Clinical Development of Immunotherapy in Urothelial Cancer
      Platinum-based chemotherapy has been the cornerstone for treating metastatic urothelial cancer, which compromises the majority of bladder cancer. While urothelial cancer is chemosensitive, p...
      Speaker: Scot Niglio, MD
      Presented at: Immuno-Oncology Virtual Event Series 2020
      1
      OCT 10, 2019 | 1:30 PM
      Precision oncology: Biomarkers for treatment selection in metastatic castration resistant prostate cancer
      Precision oncology: Biomarkers for treatment selection in metastatic...
      Metastatic castration resistant prostate cancer (mCRPC) refractory to secondary hormonal treatments such as enzalutamide or abiraterone acetate are the most lethal of prostate cancers. In thi...
      Speaker: Tian Zhang, MD, MHS
      Presented at: Cancer Research & Oncology Week Virtual Event Series 2019
      1
      FEB 27, 2019 | 1:30 PM
      Comprehensive NTRK Fusion Detection, Agnostic of the Fusion Partner, for Optimal Identification of Rare Genomic Events Using TruSightTM Oncology 500
      Comprehensive NTRK Fusion Detection, Agnostic of the Fusion Partner,...
      NTRK fusions are rare but important recent biomarkers linked to response to new TRK inhibitors. Comprehensive genomic profiling on all solid tumors permits detection of rare genomic events an...
      Speaker: Phillip Febbo, MD , Maude Champagne
      Presented at: Drug Discovery Virtual Event Series 2019
      Sponsored By: Illumina
      4
      DEC 05, 2017 | 6:00 AM
      WEBINAR: Androgen signaling in advanced prostate cancer models using noninvasive hyper polarized MRI and mass spectrometry
      WEBINAR: Androgen signaling in advanced prostate cancer models...
      DATE: December 5th, 2017TIME:  6:00AM PTAndrogen receptor (AR) signaling remains a driver in the lethal phenotype of prostate cancer, castrate resistant prostate cancer (CRPC). Nov...
      Speaker: Mark Titus, PhD
      Sponsored By: Agilent
      4
      AUG 11, 2016 | 11:00 AM
      RNA-ISH for Long non-coding RNAs - new game changers in pathology
      RNA-ISH for Long non-coding RNAs - new game changers in pathology
      DATE: August 11, 2016 TIME: 11:00AM PST, 2:00PM ET, 7:00PM GMT The central dogma that forms the backbone of molecular biology is that DNA codes for RNA (transcription) which then c...
      Speaker: Rohit Mehra, M.D.
      Sponsored By: Advanced Cell Diagnostics, Advanced Cell Diagnostics
      12
      SEP 30, 2015 | 10:30 AM
      The Evolving Role of Image-Guided Prostate Cancer Targeting and Ablation: Moving Towards Personalized Medicine
      The Evolving Role of Image-Guided Prostate Cancer Targeting and...
      The management of prostate cancer (PCa) continues to evolve and does so at a rapid rate. Research and technological developments continue to refine our definitions and management of this comp...
      Speaker: Rajan Gupta, MD , Thomas Polascik, MD , Stacy Loeb, MD
      Presented at: Cancer Research & Oncology Week Virtual Event Series 2015
      0
      OCT 16, 2013 | 7:00 AM
      C.E. CREDITS
      Prognostic, predictive, and surrogate biomarkers in men with castration resistant metastatic prostate cancer
      Prognostic, predictive, and surrogate biomarkers in men with castration...
      With the rapid rise in the number of therapeutic options for men with castration-resistant prostate cancer (CRPC) comes increasingly complicated treatment decision-making, emphasizing the nee...
      Speaker: Andrew Armstrong, MD ScM FACP
      Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
      96
    OCT 30, 2023 | 8:00 PM
    Capillary electrophoresis in cancer research today:
    Capillary electrophoresis in cancer research today:
    Description: Join this two-part webinar to learn how capillary electrophoresis (CE) complements sequencing technologies, such as next generation sequencing, that are being used by cancer res...
    Speaker: Steve Jackson, PhD , Dr. Somak Roy, MD
    Sponsored By: Thermo Fisher Scientific
    11
    OCT 26, 2023 | 8:00 AM
    Capillary electrophoresis in cancer research today:
    Capillary electrophoresis in cancer research today:
    Description: Join this two-part webinar to learn when capillary electrophoresis is an ideal choice relative to other various sequencing technologies – such as next generation sequencin...
    Speaker: Steve Jackson, PhD , Dr. Somak Roy, MD
    Sponsored By: Thermo Fisher Scientific
    23
    JUN 02, 2021 | 12:00 AM
    IDO in Melanoma..... Deserves Further Evaluation
    IDO in Melanoma..... Deserves Further Evaluation
    Learning Objectives: 1. Learn about IDO pathway 2. IDO rule in cancer...
    Speaker: Yousef Zakharia, MD
    Presented at: Immuno-Oncology Virtual Event Series 2021
    1
    OCT 21, 2020 | 9:25 PM
    The role of PARPis and HRD testing in advanced ovarian cancer
    The role of PARPis and HRD testing in advanced ovarian cancer
    High grade serous ovarian cancer is characterized by genomic instability, with ~50% of advanced tumors harboring homologous recombination repair (HRR) pathway deficiency (HRD). HRD results i...
    Speaker: Natalie Ngoi, MBBS, MMed, MRCP
    Presented at: OncomineWorld Autumn: A virtual NGS education meeting
    1
    OCT 21, 2020 | 9:25 PM
    The role of PARPis and HRD testing in advanced ovarian cancer
    The role of PARPis and HRD testing in advanced ovarian cancer
    High grade serous ovarian cancer is characterized by genomic instability, with ~50% of advanced tumors harboring homologous recombination repair (HRR) pathway deficiency (HRD). HRD results i...
    Speaker: Natalie Ngoi, MBBS, MMed, MRCP
    Presented at: OncomineWorld 2022: A Virtual NGS Education Meeting
    0
     
     
  • OCT 07, 2020 | 12:00 AM
    Immunotherapy in Prostate and Renal Cell Carcinoma: Panoply of Futuristic Therapies
    Immunotherapy in Prostate and Renal Cell Carcinoma: Panoply of...
    Immune therapy approaches are being used in many different solid cancers today including clear cell renal carcinoma (mccRCC) and metastatic prostate adenocarcinoma. Over the past few years i...
    Speaker: Benjamin Maughan, MD, PharmD
    Presented at: Cancer Research & Oncology Week Virtual Event Series 2020
    4
    JUN 03, 2020 | 6:00 AM
    Keynote Presentation: Development of Rational Immunotherapy Combinations to Overcome the Immunosuppressive Prostate Tumor Microenvironment
    Keynote Presentation: Development of Rational Immunotherapy Combinations...
    Immune checkpoint therapies targeting the CTLA-4 and PD-(L)1 pathways have been largely clinically disappointing for patients with prostate cancer. This can be attributed to the highly immun...
    Speaker: Sumit K. Subudhi, MD, PhD
    Presented at: Immuno-Oncology Virtual Event Series 2020
    1
    JUN 03, 2020 | 12:00 AM
    Define challenges of tissue-based biomarker development for Immuno-Oncology Therapy
    Define challenges of tissue-based biomarker development for Immuno-Oncology...
    Learning Objectives: 1. Define applications of approved and experimental (multiplexing IF) biomarker assessment in Immuno-Oncology 2. Define bottlenecks and areas of improvement to current t...
    Speaker: Houssein Sater, MD
    Presented at: Immuno-Oncology Virtual Event Series 2020
    1
    JUN 03, 2020 | 12:00 AM
    Clinical Development of Immunotherapy in Urothelial Cancer
    Clinical Development of Immunotherapy in Urothelial Cancer
    Platinum-based chemotherapy has been the cornerstone for treating metastatic urothelial cancer, which compromises the majority of bladder cancer. While urothelial cancer is chemosensitive, p...
    Speaker: Scot Niglio, MD
    Presented at: Immuno-Oncology Virtual Event Series 2020
    1
    OCT 10, 2019 | 1:30 PM
    Precision oncology: Biomarkers for treatment selection in metastatic castration resistant prostate cancer
    Precision oncology: Biomarkers for treatment selection in metastatic...
    Metastatic castration resistant prostate cancer (mCRPC) refractory to secondary hormonal treatments such as enzalutamide or abiraterone acetate are the most lethal of prostate cancers. In thi...
    Speaker: Tian Zhang, MD, MHS
    Presented at: Cancer Research & Oncology Week Virtual Event Series 2019
    1
     
     
  • FEB 27, 2019 | 1:30 PM
    Comprehensive NTRK Fusion Detection, Agnostic of the Fusion Partner, for Optimal Identification of Rare Genomic Events Using TruSightTM Oncology 500
    Comprehensive NTRK Fusion Detection, Agnostic of the Fusion Partner,...
    NTRK fusions are rare but important recent biomarkers linked to response to new TRK inhibitors. Comprehensive genomic profiling on all solid tumors permits detection of rare genomic events an...
    Speaker: Phillip Febbo, MD , Maude Champagne
    Presented at: Drug Discovery Virtual Event Series 2019
    Sponsored By: Illumina
    4
    DEC 05, 2017 | 6:00 AM
    WEBINAR: Androgen signaling in advanced prostate cancer models using noninvasive hyper polarized MRI and mass spectrometry
    WEBINAR: Androgen signaling in advanced prostate cancer models...
    DATE: December 5th, 2017TIME:  6:00AM PTAndrogen receptor (AR) signaling remains a driver in the lethal phenotype of prostate cancer, castrate resistant prostate cancer (CRPC). Nov...
    Speaker: Mark Titus, PhD
    Sponsored By: Agilent
    4
    AUG 11, 2016 | 11:00 AM
    RNA-ISH for Long non-coding RNAs - new game changers in pathology
    RNA-ISH for Long non-coding RNAs - new game changers in pathology
    DATE: August 11, 2016 TIME: 11:00AM PST, 2:00PM ET, 7:00PM GMT The central dogma that forms the backbone of molecular biology is that DNA codes for RNA (transcription) which then c...
    Speaker: Rohit Mehra, M.D.
    Sponsored By: Advanced Cell Diagnostics, Advanced Cell Diagnostics
    12
    SEP 30, 2015 | 10:30 AM
    The Evolving Role of Image-Guided Prostate Cancer Targeting and Ablation: Moving Towards Personalized Medicine
    The Evolving Role of Image-Guided Prostate Cancer Targeting and...
    The management of prostate cancer (PCa) continues to evolve and does so at a rapid rate. Research and technological developments continue to refine our definitions and management of this comp...
    Speaker: Rajan Gupta, MD , Thomas Polascik, MD , Stacy Loeb, MD
    Presented at: Cancer Research & Oncology Week Virtual Event Series 2015
    0
    OCT 16, 2013 | 7:00 AM
    C.E. CREDITS
    Prognostic, predictive, and surrogate biomarkers in men with castration resistant metastatic prostate cancer
    Prognostic, predictive, and surrogate biomarkers in men with castration...
    With the rapid rise in the number of therapeutic options for men with castration-resistant prostate cancer (CRPC) comes increasingly complicated treatment decision-making, emphasizing the nee...
    Speaker: Andrew Armstrong, MD ScM FACP
    Presented at: Cancer: Research, Discovery and Therapeutics Virtual Event Series 2013
    96
    Let's Talk Science. Let's Talk Medicine.

    The leading scientific social networking website and producer of educational virtual events and webinars.

    About Us The Team Contact Us Careers Media Kit Virtual Events Posters Multimedia Blog Press Room Science Store Gift Card Balance
    Continuing Education Scholarships Leaderboard Order Policy Shipping Policy Privacy Policy Terms and Conditions User Agreement User Data Request Copyrights Support Chati
    © 2008-2025 Labroots Inc.
    Opens in a new window Opens an external site Opens an external site in a new window
    Modal title